Average Co-Inventor Count = 13.07
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Compugen Ltd. Corporation (14 from 60 patents)
14 patents:
1. 10098934 - Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
2. 9555087 - Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
3. 9375466 - Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
4. 9107862 - Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
5. 8415455 - Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
6. 7906635 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of ovarian cancer
7. 7741433 - Diagnostic markers, especially for in vivo imaging and assays and methods of use thereof
8. 7714100 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of cardiac disease
9. 7667001 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer
10. 7569662 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer
11. 7553948 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of ovarian cancer
12. 7528243 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer
13. 7488813 - Diagnostic markers, especially for in vivo imaging, and assays and methods of use thereof
14. 7345142 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of cardiac disease